The UFC and its drug-testing partner The U.S. Anti-Doping Agency (USADA) has been drawn into the ongoing dispute between the USADA and the Nevada Athletic Commission (NAC). Following yesterday’s revelations regarding Floyd Mayweather’s use of a saline IV before his May bout with Manny Pacquiao in a blockbuster report by Thomas Hauser on our parent site SBNation.com, LA Times reporter Lance Pugmire is tweeting from the NAC and has some revelations regarding UFC heavyweight Frank Mir:
Told by Nevada commission members that UFC fighter Frank Mir similarly obtained a TUE from USADA last week that Nevada ruled inadmissible.
— Lance Pugmire (@latimespugmire) September 10, 2015
“They’re confusing the fighters,” Nevada commission executive director Bob Bennett said of USADA.
— Lance Pugmire (@latimespugmire) September 10, 2015
Mir had been taking Adderall, I’m told by the commission, he stopped when told to.
— Lance Pugmire (@latimespugmire) September 10, 2015
Adderall is a stimulant commonly used for the treatment of attention deficit hyperactivity disorder (ADHD). Mir previously had a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) before the NAC banned that practice.
Mir lost a decision to Andrei Arlovski at UFC 191.
About the author
